Study of a Series of Patients Treated for Retrograde Cricopharyngeal Muscle Dysfunction Syndrome

Recruiting

• Conditions: Deglutition Disorders

• Registration Number: NCT06174831
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

R-CPD syndrome (Retrograde Cricopharyngeal Dysfunction syndrome) is an inability to burp.

It is a syndrome whose diagnosis is clinical, and for which there is effective treatment. Recently treated in the United States (first publication in 2019), this syndrome affects many patients in France and is currently unknown.

This study concerns a series of patients treated at the University Hospitals of Strasbourg for a syndrome of retrograde dysfunction of the cricopharyngeus muscle having been treated by injection of botulinum toxin into the cricopharyngeus muscle.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-01
• Status Verified: 2023-10
• Study First Submitted: 2023-10-23
• Study First Submitted QC: 2023-12-14
• Last Update Submitted: 2023-12-14
• Study First Posted: 2023-12-18
• Last Update Posted: 2023-12-18
• Primary Completion: 2024-01
• Study Completion: 2024-01-19

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Major subject (≥18 years old)
• Subject treated by injection of botulinum toxin into the cricopharyngeal muscle after having had a diagnosis of R-CPD in consultation between January 1, 2022 and December 31, 2022
• Subject not opposing the reuse of their data for the purposes of this research.

Exclusion Criteria

• Subject having expressed opposition to participating in the study,
• Subject under judicial protection
• Subject under guardianship or curatorship

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective description of the characteristics of a series of patients treated for dysphagia syndrome	Through study completion, an average of 2 months	Retrospective study of medical files of patients treated in HUS between January 1, 2022 and December 31, 2022

Trial Locations

Locations (1)

Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France; 🇫🇷 Strasbourg, France